Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DURECT Corp (NASDAQ:DRRX)

1.72
Delayed Data
As of 10:58am ET
 -0.04 / -2.27%
Today’s Change
0.99
Today|||52-Week Range
2.71
-22.17%
Year-to-Date
No recent news for DURECT Corp.

Today’s Trading

Previous close1.76
Today’s open1.75
Day’s range1.70 - 1.78
Volume166,834
Average volume (3 months)673,936
Market cap$241.8M
Dividend yield--
Data as of 10:58am ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)+5.00%
Earnings growth (this year)-34.21%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-1.43%
P/E ratioNM
Price/Sales13.70
Price/Book14.41

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...-0.34-2.50%
CNCEConcert Pharmaceutic...+0.18+1.69%
COLLCollegium Pharmaceut...-0.05-0.47%
IDRAIdera Pharmaceutical...0.000.00%
Data as of 11:13am ET, 08/25/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$19.1M
Annual profit (last year)-$22.7M
Net profit margin-118.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Scientific Officer
Felix Theeuwes
President, Chief Executive Officer &
Director
James E. Brown
Corporate headquarters
Cupertino, California

Forecasts

Partner Offers

Search for Jobs